US FDA Approval Of Novo Nordisk's Victoza For Young T2D Patients A Treatment Milestone

 
• By Sten Stovall
  
Blood sample
Move Gives Young T2D patients First New Treatment Option In Nearly 20 Years • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip